FDA approves new Moderna COVID-19 vaccine

axios.com/2025/05/31/fda-approves-moderna-mnexspike-covid-19-vaccine

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older and those 12 to 64 years old with at least one underlying condition that could put them at risk of severe infection, the company said Saturday.
The big picture: It was the first…

This story appeared on axios.com, 2025-05-31 14:19:07.
The Entire Business World on a Single Page. Free to Use →